While both Hb-lipo and FAL-Hb-lipo could accumulate in tumors, ICG-HAuNS and FAL-ICG-HAuNS showed a higher tumor-targeting efficiency, demonstrating a clear ICG signal at 2 h postinjection (Fig. 5a). Here, GSTM1 is linked to neoplasm.